在虫药安全性,有效性和耐药性中的P-糖蛋白
Anne Lespine1, Clara Blancfuney1, Roger Prichard2
1INTHERES, Université de Toulouse, INRAE, ENVT, Toulouse, France.
Trends in parasitology
|August 21, 2024
概括
P-糖蛋白 (PGP) 载体限制了药物的有效性. 准线虫特定的NHR-8可以克服对宏环乳如ivermectin的耐药性.
科学领域:
- 生物化学 生物化学
- 寄生虫学的寄生虫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 糖蛋白 (PGP) 是一种关键的跨膜载体,可以保护哺乳动物免受毒素的侵害.
- PGP可以降低抗虫药物的疗效,包括ivermectin (IVM) 和其他宏环乳 (MLs).
- 在寄生虫感染中,PGP对抗药性和宿主保护的作用至关重要.
研究的目的:
- 分析PGPs在限制宿主中药物毒性的作用.
- 调查PGP对线虫抗除剂耐药性的贡献.
- 为了确定克服ML抗性的潜在治疗点.
主要方法:
- 分析药物运输中的PGP功能.
- 研究NHR-8在调节PGP表达中的作用.
- 对宿主和线虫的PGP活性进行比较研究.
主要成果:
- PGPs在保护宿主免受毒素和促进抗甲虫药物耐药性方面发挥着双重作用.
- 缺乏选择性PGP抑制剂阻碍了治疗策略.
- NHR-8可以调节多个参与线甲虫抗虫剂耐药性的PGP.
结论:
- 准线虫特定的NHR-8是一种有前途的策略,可以提高对ML杀虫剂的敏感性.
- 了解PGP-NHR-8的相互作用可以为寄生虫疾病带来新的治疗方法.
- NHR-8代表了对抗线虫中抗甲虫药物耐药性的特定目标.
相关概念视频
Carrier-Mediated Transport
317
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
317
GPCRs Regulate Adenylyl Cylase Activity
5.4K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.4K
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
167
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
167


